Cholelithiasis resident survival guide: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 31: | Line 31: | ||
==Management== | ==Management== | ||
Shown below is a diagram depicting the management of cholelithiasis according to the Society for Surgery of the Alimentary Tract (SSAT) | Shown below is a diagram depicting the management of cholelithiasis according to the Society for Surgery of the Alimentary Tract (SSAT)<ref name="Duncan-2012">{{Cite journal | last1 = Duncan | first1 = CB. | last2 = Riall | first2 = TS. | title = Evidence-based current surgical practice: calculous gallbladder disease. | journal = J Gastrointest Surg | volume = 16 | issue = 11 | pages = 2011-25 | month = Nov | year = 2012 | doi = 10.1007/s11605-012-2024-1 | PMID = 22986769 }}</ref> and data from multiple studies | ||
{{familytree/start |summary=Cholelithiasis}} | {{familytree/start |summary=Cholelithiasis}} | ||
Line 77: | Line 77: | ||
{{familytree | | | | | | K01 | | K02 |!| | K03 | | K04 | |K01=Poor surgical candidates|K02=Good surgical candidates|K03=Repeat TAUSG in few weeks (especially for <3 mm stones)|K04=Consider evaluation for alternate diagnosis of abdominal pain}} | {{familytree | | | | | | K01 | | K02 |!| | K03 | | K04 | |K01=Poor surgical candidates|K02=Good surgical candidates|K03=Repeat TAUSG in few weeks (especially for <3 mm stones)|K04=Consider evaluation for alternate diagnosis of abdominal pain}} | ||
{{familytree | | | | | | |!| | | |!| |!| |,|^|-|-|-|.|}} | {{familytree | | | | | | |!| | | |!| |!| |,|^|-|-|-|.|}} | ||
{{familytree | | | | | | L01 | | L02 |`|-| L03 | | L04 |-|L05|-|L06|-|L07|L01=Ursodeoxycholic acid 10/14 mg/kg/day before bed time for 1-2 years/more<ref name="Tomida-1999">{{Cite journal | last1 = Tomida | first1 = S. | last2 = Abei | first2 = M. | last3 = Yamaguchi | first3 = T. | last4 = Matsuzaki | first4 = Y. | last5 = Shoda | first5 = J. | last6 = Tanaka | first6 = N. | last7 = Osuga | first7 = T. | title = Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis. | journal = Hepatology | volume = 30 | issue = 1 | pages = 6-13 | month = Jul | year = 1999 | doi = 10.1002/hep.510300108 | PMID = 10385632 }}</ref>|L02=Laparoscopic cholecystectomy (as early as possible to avoid gallstone related complications)|L03=Gallstones/biliary sludge during TAUSG|L04= No gallstones/biliary sludge during TAUSG|L05=<div style="float: left; text-align: left; line-height: 150% ">❑ Biliary colic<br>❑ Abnormal LFT<BR>❑ Dilated CBD in TAUSG<BR>❑ Sphincter of Oddi pressure >40 mmHg in sphincter of Oddi manometry</div>|L06=''' | {{familytree | | | | | | L01 | | L02 |`|-| L03 | | L04 |-|L05|-|L06|-|L07|L01=Ursodeoxycholic acid 10/14 mg/kg/day before bed time for 1-2 years/more<ref name="Tomida-1999">{{Cite journal | last1 = Tomida | first1 = S. | last2 = Abei | first2 = M. | last3 = Yamaguchi | first3 = T. | last4 = Matsuzaki | first4 = Y. | last5 = Shoda | first5 = J. | last6 = Tanaka | first6 = N. | last7 = Osuga | first7 = T. | title = Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis. | journal = Hepatology | volume = 30 | issue = 1 | pages = 6-13 | month = Jul | year = 1999 | doi = 10.1002/hep.510300108 | PMID = 10385632 }}</ref>|L02=Laparoscopic cholecystectomy (as early as possible to avoid gallstone related complications)|L03=Gallstones/biliary sludge during TAUSG|L04= No gallstones/biliary sludge during TAUSG|L05=<div style="float: left; text-align: left; line-height: 150% ">'''Diagnostic criteria:'''<ref name="Behar-2006">{{Cite journal | last1 = Behar | first1 = J. | last2 = Corazziari | first2 = E. | last3 = Guelrud | first3 = M. | last4 = Hogan | first4 = W. | last5 = Sherman | first5 = S. | last6 = Toouli | first6 = J. | title = Functional gallbladder and sphincter of oddi disorders. | journal = Gastroenterology | volume = 130 | issue = 5 | pages = 1498-509 | month = Apr | year = 2006 | doi = 10.1053/j.gastro.2005.11.063 | PMID = 16678563 }}</ref><br>❑ Biliary colic<br>❑ Abnormal LFT<br>❑ Normal amylase/lipase<BR>❑ Dilated CBD in TAUSG<BR>❑ Sphincter of Oddi pressure >40 mmHg in sphincter of Oddi manometry</div>|L06=Suspect '''sphincter of Oddi dysfunction'''|L07=❑ Nifedipine or nitrates<br>❑ ERCP with endoscopic sphincterotomy}} | ||
{{familytree | | | | | | | | | | | | | | | | | | | |!| | | | | | | |}} | {{familytree | | | | | | | | | | | | | | | | | | | |!| | | | | | | |}} | ||
{{familytree | | | | | | | | | | | | | | | | | | | M01 | | |M01=Cholecystokinin stimulated HIDA scan}} | {{familytree | | | | | | | | | | | | | | | | | | | M01 | | |M01=Cholecystokinin stimulated HIDA scan}} |
Revision as of 23:59, 28 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vendhan Ramanujam M.B.B.S [2]
Definitions
Terms | Definitions |
---|---|
Cholelithiasis (gallstones) | Cholelithiasis (gallstones) are crystallized pieces of bile including cholesterol and bilirubin in the gallbladder, which can range from microscopic to more than one inch in size and from one stone to hundreds in number. |
Microlithiasis (biliary sludge) | Microlithiasis (biliary sludge) are crystals and stones in the gallbladder that are too small to see with the naked eye. |
Asymptomatic (incidential) cholelithiasis | Asymptomatic (incidential) cholelithiasis refers to incidentally detected gallstones during routine ultrasound for other abdominal conditions or occasionally by palpation of the gallbladder at operation in patients who do not have any abdominal symptoms or have symptoms that are not thought to be due to gallstones. |
Symptomatic and uncomplicated cholelithiasis | Symptomatic and uncomplicated cholelithiasis refers to stones in the gallbladder that are associated with biliary colic in the absence of complications such as acute cholecystitis, cholangitis, or gallstone pancreatitis. |
Symptomatic and complicated cholelithiasis | Symptomatic and complicated cholelithiasis refers to stones in the gallbladder that are associated with upper abdominal pain, not typical of biliary colic in the presence of complications such as acute cholecystitis, cholangitis, or gallstone pancreatitis. |
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Cholelithiasis does not have any life-threatening causes.
Common Causes
Management
Shown below is a diagram depicting the management of cholelithiasis according to the Society for Surgery of the Alimentary Tract (SSAT)[2] and data from multiple studies
Characterize the symptoms: ❑ Asymptomatic ❑ Symptomatic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Asymptomatic: Gallstones identified during ❑ Imaging evaluation of abdominal and pelvic diseases ❑ Palpation of gallbladder at operation | Symptomatic: ❑ Abdominal pain | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Asymptomatic cholelithiasis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ Observation ❑ Expectant management ❑ Prophylactic cholecystectomy | ❑ Biliary colic
| ❑ Abdominal pain not typical of biliary colic | Atypical symptoms: ❑ Diffuse abdominal pain ❑ Retrosternal heart burn ❑ Fluid regurgitation ❑ Belching ❑ Abdominal distension/bloating ❑ Early satiety/fullness after meals | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Examine the patient: ❑ No significant findings | Examine the patient: ❑ Febrile ❑ Jaundice ❑ Tachycardia ❑ Tachypnea ❑ Hypotension ❑ Abdominal distension and/or tenderness ❑ Abdominal guarding ❑ Murphy's sign ❑ Altered mental status | Examine the patient | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Order laboratory tests: ❑ CBC ❑ BMP ❑ Total bilirubin ❑ Direct bilirubin ❑ Albumin ❑ AST ❑ ALT ❑ Alkaline phosphatase ❑ GGT ❑ Amylase ❑ Lipase | Symptomatic & complicated cholelithiasis: Consider evaluation of cholelithiasis associated complications ± choledocholithiasis & choledocholithiasis associated complications | Consider evaluation for alternate diagnosis of abdominal pain | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Order transabdominal USG (TAUSG) | Consider: ❑ CBC ❑ BMP ❑ Total bilirubin ❑ Direct bilirubin ❑ Albumin ❑ AST ❑ ALT ❑ Alkaline phosphatase ❑ GGT ❑ Amylase ❑ Lipase ❑ TAUSG ❑ HIDA ❑ EUS/MRCP ❑ ERCP ❑ Blood C & S | Consider: ❑ CBC ❑ BMP ❑ Total bilirubin ❑ Direct bilirubin ❑ Albumin ❑ AST ❑ ALT ❑ Alkaline phosphatase ❑ GGT ❑ Amylase ❑ Lipase sphincter of Oddi dysfunction Urine analysis ❑ EKG ❑ CXR ❑ Esophageal manometry ❑ UGI endoscopy ❑ CT abdomen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diagnostic criteria: ❑ Biliary colic ❑ No significant findings during PE ❑ Normal CBC, LFT & pancreatic enzymes ❑ Gallstones/biliary sludge during TAUSG | Manage accordingly | Manage accordingly | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Meets diagnostic criteria: Symptomatic & Uncomplicated cholelithiasis | Does not meet diagnostic criteria: ❑ No gallstones/biliary sludge during TAUSG | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Acute pain management
| w/ classical biliary colic | w/o classical biliary colic ± atypical symptoms | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Poor surgical candidates | Good surgical candidates | Repeat TAUSG in few weeks (especially for <3 mm stones) | Consider evaluation for alternate diagnosis of abdominal pain | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ursodeoxycholic acid 10/14 mg/kg/day before bed time for 1-2 years/more[3] | Laparoscopic cholecystectomy (as early as possible to avoid gallstone related complications) | Gallstones/biliary sludge during TAUSG | No gallstones/biliary sludge during TAUSG | Diagnostic criteria:[4] ❑ Biliary colic ❑ Abnormal LFT ❑ Normal amylase/lipase ❑ Dilated CBD in TAUSG ❑ Sphincter of Oddi pressure >40 mmHg in sphincter of Oddi manometry | Suspect sphincter of Oddi dysfunction | ❑ Nifedipine or nitrates ❑ ERCP with endoscopic sphincterotomy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cholecystokinin stimulated HIDA scan | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ursodeoxycholic acid 10/14 mg/kg/day before bed time for 1-2 years | Microlithiasis | EUS | GBEF >40% | GBEF <40% | Functional Gallbladder disorder | Chloecystectomy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consider evaluation for alternate diagnosis of abdominal pain | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Do's
Dont's
References
- ↑ Lammert, F.; Miquel, JF. (2008). "Gallstone disease: from genes to evidence-based therapy". J Hepatol. 48 Suppl 1: S124–35. doi:10.1016/j.jhep.2008.01.012. PMID 18308417.
- ↑ Duncan, CB.; Riall, TS. (2012). "Evidence-based current surgical practice: calculous gallbladder disease". J Gastrointest Surg. 16 (11): 2011–25. doi:10.1007/s11605-012-2024-1. PMID 22986769. Unknown parameter
|month=
ignored (help) - ↑ Tomida, S.; Abei, M.; Yamaguchi, T.; Matsuzaki, Y.; Shoda, J.; Tanaka, N.; Osuga, T. (1999). "Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis". Hepatology. 30 (1): 6–13. doi:10.1002/hep.510300108. PMID 10385632. Unknown parameter
|month=
ignored (help) - ↑ Behar, J.; Corazziari, E.; Guelrud, M.; Hogan, W.; Sherman, S.; Toouli, J. (2006). "Functional gallbladder and sphincter of oddi disorders". Gastroenterology. 130 (5): 1498–509. doi:10.1053/j.gastro.2005.11.063. PMID 16678563. Unknown parameter
|month=
ignored (help)